Neochem bio solutions limited IPO Overview
Neochem bio solutions limited IPO is a SME public issue offered through a Book Building issue with a total issue size of ₹44.97 Cr. The IPO price band is set at ₹93 to ₹98 per share, and retail investors can apply with a minimum investment of ₹2.35 L as per IPO guidelines.
The Neochem bio solutions limited IPO opens on 2 Dec 2025 and closes on 4 Dec 2025. The IPO allotment is expected to be finalized on 5 Dec 2025, and the equity shares are proposed to be listed on NSE on 9 Dec 2025.
Investors can refer to the Neochem bio solutions limited IPO RHP-DRHP for detailed information. The issue is managed by Vivro Financial Services Pvt.Ltd. as the book running lead manager, while MUFG Intime India Private Limited (Link Intime) is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About neochem bio solutions limited
The company products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
The company offer a comprehensive range of textile and garment washing auxiliaries such as pre-treatment, dyeing, finishing, printing and coating applications across all fabric and garment substrates compatible with various processing machines.
The company has its manufacturing facility located at Saket Industrial Estate, Village Moraiya, Ta. Sanand, Dist-Ahmedabad, which has an installed capacity of 22,000 metric ton per annum (“MTPA”) with a total area of 6,763 square meters.
Competitve Strengths:
Strengthening the presence across end-user application industries
Commitment to continuous development of innovative performance chemistries and sustainable solutions
Continued focus on expansion of geographical presence
Leverage existing strategic collaborations and partnerships to diversify end user industries
Investment Objective
Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company
General Corporate Purposes